HOME >> MEDICINE >> NEWS
Summer update: Melanoma research progress suggests optimism for future cures

(Philadelphia) In a nation of sun-worshipers, melanoma is on the rise. Although doctors warn their patients to slather on sunscreen and seek cover in the shade, messages about sun safety still compete for the public's attention with magazine covers promoting that supposedly "healthy" tan look. While many other cancers are declining, melanoma the deadliest form of skin cancer is the fastest growing cancer in the U.S. Early melanoma is highly treatable, but there are limited therapies for people with advanced stages of the disease.

At The Wistar Institute, professor Meenhard Herlyn, D.V.M., is taking a broad-based approach to understanding melanoma in order to develop better treatments for people with the disease. Herlyn leads the largest melanoma research laboratory outside the National Institutes of Health, supported in part by a prestigious SPORE (Specialized Program of Research Excellence) federal grant, one of only three such awards nationwide.

"We are closer to a cure for melanoma than ever before because we have learned so much in the past few years," Herlyn says. "I'm optimistic that in the not-too-distant future we will be able to offer patients meaningful new treatment options."

An important thrust of Herlyn's research has been to develop artificial skin models in order to study melanoma. Tumors don't exist in isolation but rather interact with other surrounding cells and tissues what scientists call the tumor microenvironment and recent cancer research has focused on studying tumors in this dynamic context. Herlyn's skin models enable him to replicate the steps in melanoma progression. The development of melanoma is complex; while researchers know that UV light triggers melanoma both through laboratory research, including earlier work by Herlyn, as well as statistical associations the precise chain of events leading to tumor development has remained elusive.

In particular, Herlyn's group has been working to understand
'"/>

Contact: Franklin Hoke
hoke@wistar.org
215-898-3716
The Wistar Institute
19-Jun-2006


Page: 1 2 3

Related medicine news :

1. Summer sun safety
2. Press update: The World Congress of Cardiology 2006, Barcelona Spain, September 2-6
3. Melanoma vaccine strategy shows promise in laboratory experiments
4. Melanoma risk only partially associated vith exposure to UVB from sunlight
5. Melanoma research receives a massive funding boost
6. 1 of 2 pediatric kidney disease research centers in world established
7. Stanford researchers find culprit in aging muscles that heal poorly
8. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
9. Indiana University Imaging Center receives $6M grant for kidney research
10. Penn researchers discover novel pathway for increasing good cholesterol
11. New research discovers independent brain networks control human walking

Post Your Comments:
(Date:5/24/2013)... 23 May 2013, Paris, France: A new investigational device ... use with the Sapien XT Transcatheter Heart Valve was ... first-in-human feasibility study of its use in high-risk aortic ... system acts as an anchor to help stabilise the ... native leaflets in the heart are captured between the ...
(Date:5/24/2013)... The producers of Health Briefs TV ... North Carolina. It is one of the largest cities in ... city is populated with more than a million people who ... both North and South Carolina. Viewers who are interested in ... into WAXN-TV 64 Eyewitness News during the month of May. ...
(Date:5/24/2013)... New York, NY (PRWEB) May 24, 2013 ... nutrition school, is happy to announce that it has donated ... that supports the women held captive in Cleveland, Ohio. , ... Gina de Jesus, Michelle Knight, and Amanda Berry and her ... captive for a decade, we were shocked and horrified,” said ...
(Date:5/24/2013)... missed more than half of recommended well-child visits had ... children who attended most of their visits, according to ... of Managed Care . The study included more than ... Children with chronic conditions like asthma and heart disease ... missed visits, according to the study. In fact, ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 The Icahn ... Dynamics International (CDI) exclusive license rights to commercially ... regenerative medicine applications. These cells are capable of further ... including cardiomyocytes, endothelial cells, and vascular smooth muscle cells, ... for damaged heart tissue. , The original agreement announced ...
Breaking Medicine News(10 mins):Health News:Feasibility trial reports deployment of new device for TAVI in aortic insufficiency 2Health News:Health Briefs TV Presents May Air Dates for Charlotte, North Carolina 2Health News:Integrative Nutrition Donates $10,000 to the Cleveland Courage Fund 2Health News:Young children who miss well-child visits are more likely to be hospitalized 2Health News:Young children who miss well-child visits are more likely to be hospitalized 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 /PRNewswire/ ... the prostate cancer treatment continuum was highlighted prominently ... the American Urological Association (AUA), in San Diego.  ... invasive high intensity focused ultrasound (HIFU) technology, the ... localize disease, and for urologists to consider minimally ...
(Date:5/23/2013)... ARBOR, Mich. , May 23, 2013  Every day, ... flow of air to his lungs. April and ... the dire predictions weren,t true. "Quite a few ... the hospital alive," says April Gionfriddo , ... were desperate. Anything that would work, we would take it ...
(Date:5/23/2013)... , May 23, 2013  Hologic, Inc. ... ), a leading developer, manufacturer and supplier of ... with an emphasis on serving the healthcare needs ... observational study in a U.S. clinical practice comparing ... (breast tomosynthesis) with conventional 2D mammography alone showed ...
Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
Cached News: